TRT on TikTok: separating testosterone facts from hype

What did @ethanbenardlive actually say?

Ethan shared lab results showing his total testosterone rose from 89 to 102 ng/dL, levels his doctor classified as hypogonadal. Rather than going straight to exogenous testosterone, he said he wants to avoid "anything that could potentially hinder his body's natural testosterone production" and is instead starting enclomiphene, a selective estrogen receptor modulator. He also mentioned adding an estrogen blocker to prevent testosterone from converting to estrogen.

He connected his low levels to obesity, acknowledged he isn't an expert, and expressed hope that the new medication would improve his mood, strength, and gym performance. He didn't make any specific dosing claims or promise a cure. The tone was personal and appropriately uncertain throughout.

Does the science back this up?

The core reasoning here is solid. Enclomiphene is a legitimate, evidence-based option for men with secondary hypogonadism who want to preserve fertility and endogenous testosterone production. A 2013 phase III trial published in the journal Fertility and Sterility (Kim et al.) found enclomiphene raised testosterone levels while maintaining or improving sperm parameters, which exogenous TRT cannot claim.

His instinct about obesity suppressing testosterone is also well-supported. Adipose tissue converts testosterone to estradiol via aromatase, and a large 2014 study in Clinical Endocrinology (Grossmann et al.) confirmed that elevated BMI is one of the strongest predictors of low total testosterone in men. At 89 ng/dL and then 102 ng/dL, his levels are well below the clinical threshold of roughly 300 ng/dL that most endocrinology guidelines use to define hypogonadism.

The combination of a SERM like enclomiphene with an aromatase inhibitor is used in clinical practice, though data on the combined approach is thinner than data on either agent alone.

What did they get wrong (or right)?

He got the big picture right. Enclomiphene is a reasonable first-line choice for a young or obese man whose hypothalamic-pituitary axis is still functional. The worry about exogenous testosterone shutting down endogenous production is legitimate. Exogenous testosterone suppresses LH and FSH, which is why men on traditional TRT commonly experience testicular atrophy and infertility.

Where he slightly oversimplified: he described enclomiphene as helping his body "boost its natural testosterone production," which is accurate but incomplete. Enclomiphene works by blocking estrogen receptors in the hypothalamus, which removes a feedback brake and causes the pituitary to release more LH and FSH. That then signals the testes to produce more testosterone. It's not a direct testosterone booster.

His framing of a separate "estrogen blocker" deserves attention. If the enclomiphene is already acting on estrogen receptors centrally, adding a peripheral aromatase inhibitor on top can over-suppress estrogen. Low estradiol in men causes joint pain, mood issues, and bone loss. Whether that combination is appropriate depends entirely on his specific labs and his physician's judgment, which he appropriately deferred to.

What should you actually know?

Enclomiphene is not FDA-approved for male hypogonadism as of 2024. It exists in a regulatory gray zone, often prescribed off-label or dispensed through compounding pharmacies. This doesn't mean it doesn't work, but it does mean quality control and standardization are not guaranteed in every formulation. Ask your provider whether you're getting a pharmaceutical-grade product.

Second, obesity-related low testosterone is partially reversible through weight loss alone. A 2013 randomized trial in JAMA (Ng Tang Fui et al.) found that significant weight reduction raised testosterone meaningfully in obese men without any hormonal intervention. Enclomiphene and lifestyle changes are not mutually exclusive, but the medication alone won't fully correct the underlying hormonal disruption if body composition doesn't change.

Third, monitoring matters. Total testosterone is just one marker. Free testosterone, SHBG, LH, FSH, estradiol, and a complete metabolic panel are all relevant when managing a case like his. Anyone watching this video who thinks they might have similar symptoms should get a full panel, not just a total testosterone number.